Acrivon Therapeutics Inc (ACRV) PT Lowered to $24 at BMO Capital
Tweet
Share
E-mailGet Alerts ACRV Hot Sheet
Price: $2.05 --0%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 9
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 9
Join SI Premium – FREE
BMO Capital analyst Etzer Darout lowered the price target on Acrivon Therapeutics Inc (NASDAQ: ACRV) to $24.00 (from $25.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Berenberg Downgrades PolyPeptide Group AG (PPGN:SW) to Hold
- Citi Downgrades FANUC Corp (6954:JP) (FANUY) to Neutral
- Ypsomed Holding AG (YPSN:SW) PT Raised to CHF480 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
